Current and future role of photodynamic therapy in chronic central serous chorioretinopathy

The dye verteporfin has great affinity to the low-density lipoprotein receptors within the new vessels, although its binding capacity with the normal endothelial cells is low. [...]we feel that these cases are primarily cases of CNV resulting as the end stage of nonhealing or recurrent CSCR.

Saved in:
Bibliographic Details
Published in:American journal of ophthalmology 2005-02, Vol.139 (2), p.393-394
Main Authors: Azad, Raj Vardhan, Rani, Alka, Pal, Nikhil, Chandra, Parijat, Sharma, Yog Raj
Format: Article
Language:English
Subjects:
Cholesterol
Choroid Diseases - diagnosis
Choroid Diseases - drug therapy
Chronic Disease
Clinical trials
Coloring Agents
Fluorescein Angiography
Humans
Indocyanine Green
Macular degeneration
Medical imaging
Photochemotherapy - trends
Photodynamic therapy
Photosensitizing Agents - therapeutic use
Porphyrins - therapeutic use
Retinal Diseases - diagnosis
Retinal Diseases - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The dye verteporfin has great affinity to the low-density lipoprotein receptors within the new vessels, although its binding capacity with the normal endothelial cells is low. [...]we feel that these cases are primarily cases of CNV resulting as the end stage of nonhealing or recurrent CSCR.
ISSN:0002-9394
1879-1891
DOI:10.1016/j.ajo.2004.09.055